— PUBLICATIONS —

Liste des publications GINECO - Cancer Ovaire 2011

  • CalypsoArticle (Annals of Oncology)
    L. Gladieff
    Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
    Gynecologic Oncology - Octobre 2011 (réf. PubMed : PMID: 21976386 [PubMed - in process])
  • CalypsoArticle (British Journal of Cancer)
    C. K. Lee
    Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer.
    British Journal of Cancer - Juillet 2011 (réf. PubMed : PMID: 21750553 [PubMed - indexed for MEDLINE] - PMCID: PMC3172911 [Available on 2012/7/26])
  • CalypsoArticle (Journal of the National Cancer Institute)
    C. K. Lee
    Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer
    Annals of Oncology - 11 Août 2011 (réf. PubMed : PMID: 21840849 [PubMed - indexed for MEDLINE])
  • CalypsoArticle (British Journal of Cancer)
    C. K. Lee
    Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
    British Journal of Cancer - Octobre 2011 (réf. PubMed : PMID: 21915127 [PubMed - indexed for MEDLINE] - PMCID: PMC3208495 [Available on 2012/10/11])
  • CalypsoArticle (Gynecologic Oncology)
    F. Joly
    Decreased hypersensitivity reactions with carboplatin pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
    Gynecologic Oncology - Août 2011 (réf. PubMed : PMID: 21575983 [PubMed - indexed for MEDLINE])
  • CalypsoArticle (Annals of Oncology)
    J. E. Kurtz
    Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
    Annals of Oncology - 14 Mars 2011 (réf. PubMed : PMID: 21402619 [PubMed - indexed for MEDLINE])
  • CartaxhyArticle (Annals of Oncology)
    A. Lortholary
    Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)
    Annals of Oncology - 11 Mai 2011 (réf. PubMed : PMID: 21562072 [PubMed - as supplied by publisher])
Haut de page
Modifié le 30-08-2016 16:16:19